Matsuo, Koji https://orcid.org/0000-0002-6232-8701
Mandelbaum, Rachel
Deshpande, Rasika R.
Nusbaum, David J.
Yoshihara, Kosuke
Machida, Hiroko
Bainvoll, Liat
Matsuzaki, Shinya
Klar, Maximilian
Roman, Lynda D.
Wright, Jason D.
Funding for this research was provided by:
Ensign Endowment for Gynecologic Cancer Research
Article History
Received: 27 March 2020
Accepted: 9 February 2022
First Online: 2 March 2022
Declarations
:
: Consultant, Clovis Oncology, Tesaro, research funding, Merck (J.D.W.); consultant, Quantgene (L.D.R.); honorarium, Chugai, book editorial expense, Springer, and investigator meeting attendance expense, VBL therapeutics (K.M.); advisory board, Tesaro, GSK (M.K.); research funding, MSD (S.M.); none for others.
: This article used publicly available deidentified data, and does not contain any studies with human participants performed by any of the authors.
: Not applicable for this study.